Showing results (1401-1410 of 1,455) with videos related to
Sort By:
Pageof 146
Nature Chemical Biology|May 13, 2008
A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activityAlessia Montagnoli, Barbara Valsasina, Valter Croci, et al.Toxins|August 26, 2021
Association of Polygenic Risk Score and Bacterial Toxins at Screening Colonoscopy with Colorectal Cancer Progression: A Multicenter Case-Control StudyAlfonso Piciocchi, Elena Angela Pia Germinario, Koldo Garcia Etxebarria, et al.The British Journal of Dermatology|August 14, 2012
The patient journey: a report of skin cancer care across EuropeM Trakatelli, S Siskou, C Proby, et al.The British Journal of Dermatology|August 14, 2012
Risk factors for actinic keratosis in eight European centres: a case-control studyA Traianou, M Ulrich, Z Apalla, et al.JACC. Cardiovascular Imaging|August 19, 2019
CT Perfusion Versus Coronary CT Angiography in Patients With Suspected In-Stent Restenosis or CAD ProgressionDaniele Andreini, Saima Mushtaq, Gianluca Pontone, et al.The Science of the Total Environment|May 25, 2021
New pedotransfer approaches to predict soil bulk density using WoSIS soil data and environmental covariates in Mediterranean agro-ecosystemsCalogero Schillaci, Alessia Perego, Elena Valkama, et al.Journal of Neurology|January 17, 2024
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational studyPiero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.Journal of Medicinal Chemistry|March 23, 2016
Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitorMaria Menichincheri, Elena Ardini, Paola Magnaghi, et al.Neurology and Therapy|March 7, 2024
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 StudyPiero Barbanti, Gabriella Egeo, Stefania Proietti, et al.Journal of Medicinal Chemistry|June 11, 2004
3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead findingPaolo Pevarello, Maria Gabriella Brasca, Raffaella Amici, et al.Pageof 146